Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Decrease in Regional Cerebral Blood Volume in Hyperintense Subcortical Lesions Inversely Correlates with Disability and Cognitive Performance

References

1. ↵
   Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-939

   CrossRefPubMedWeb of Science
2. Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991;22:1297-1302

   Abstract/FREE Full Text
3. ↵
   Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19ql2. Nat Genet 1993;3:256-259

   CrossRefPubMedWeb of Science
4. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710

   CrossRefPubMedWeb of Science
5. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350:1511-1515

   CrossRefPubMedWeb of Science
6. ↵
   Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997;56:947-964

   PubMedWeb of Science
7. Sabbadini G, Francia A, Calandriello L. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain 1995;118:207-215

   Abstract/FREE Full Text
8. ↵
   Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-739

   CrossRefPubMedWeb of Science
9. ↵
   Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452-457

   Abstract/FREE Full Text
10. ↵
    Yousry TA, Seelos K, Mayer M, et al. Characteristic MRI lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 1999;20:91-100

    Abstract/FREE Full Text
11. ↵
    Dichgans M, Filippi M, Bruening R, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 1999;52:1361-1367

    Abstract/FREE Full Text
12. ↵
    Ruchoux MM, Chabriat H, Baudrimont M, Tournier-Lasserve E, Bousser MG. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994;25:2291-2292

    FREE Full Text
13. Skehan SJ, Hutchinson M, MacErlaine DP. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. AJNR Am J Neuroradiol 1995;16:2115-2119

    Abstract
14. Chabriat H, Mrissa R, Levy C, et al. Brain stem MRI signal abnormalities in CADASIL. Stroke 1999;30:457-459

    Abstract/FREE Full Text
15. Sourander P, Walinder J. Hereditary multi-infarct dementia: morphological and clinical studies of a new disease. Acta Neuropathol (Berl) 1977;39:247-254

    CrossRefPubMed
16. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-303

    PubMedWeb of Science
17. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641

    PubMedWeb of Science
18. Rother J, Guckel F, Neff W, Schwartz A, Hennerici M. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging. Stroke 1996;27:1088-1093

    Abstract/FREE Full Text
19. ↵
    Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar imaging. Radiology 1996;199:391-401

    PubMedWeb of Science
20. ↵
    Mayer M, Straube A, Bruening R, et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol 1999;246:526-532

    CrossRefPubMedWeb of Science
21. ↵
    de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin “handicap” grades after stroke. Stroke 1995;26:2027-2030

    Abstract/FREE Full Text
22. ↵
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198

    CrossRefPubMedWeb of Science
23. ↵
    Zaudig M, Mittelhammer J, Hiller W, et al. SIDAM: a structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 1991;21:225-236

    CrossRefPubMedWeb of Science
24. Bruening R, Kwong KK, Vevea MJ, et al. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR Am J Neuroradiol 1996;17:831-840

    Abstract
25. Meier P, Zierler KL. On the theory of the indicator dilution method for measurements of blood volume and flow. J Appl Physiol 1954;12:731-744
26. Rosen BR, Belliveau JW, Buchbinder BR, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991;19:285-292

    PubMedWeb of Science
27. ↵
    Wu RH, Bruening R, Berchtenbreiter C, et al. MRI assessment of cerebral blood volume in patients with brain infarction. Neuroradiology 1998;40:496-502

    CrossRefPubMed
28. ↵
    Wenz F, Rempp K, Brix G, et al. Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC). Magn Reson Imaging 1996;14:157-162

    CrossRefPubMedWeb of Science
29. ↵
    Ruchoux MM, Maurage CA. Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol 1998;24:60-65

    CrossRefPubMedWeb of Science
30. ↵
    Chabriat H, Pappata S, Poupon C, et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 1999;30:2637-2643

    Abstract/FREE Full Text
31. ↵
    Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-1597

    Abstract/FREE Full Text
32. Karonen JO, Vanninen RL, Liu Y, et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke: ischemic penumbra predicts infarct growth. Stroke 1999;30:1583-1590

    Abstract/FREE Full Text
33. Jung HH, Bassetti C, Tournier-Lasserve E, et al. Cerebral autosomal dominant arteriopathy with subcortical, infarcts and leukoencephalopathy: a clinicopathological and genetic study of a Swiss family. J Neurol Neurosurg Psychiatry 1995;59:138-143

    Abstract/FREE Full Text
34. Warach S, Levin JM, Schomer DL, Holman BL, Edelman RR. Hyperperfusion of ictal seizure focus demonstrated by MR perfusion imaging. AJNR Am J Neuroradiol 1994;15:965-968

    Abstract/FREE Full Text
35. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174

    CrossRefPubMedWeb of Science
36. Merrick MV. Measuring the ratio of rCBV to rCBF with SPECT. J Nucl Med 1990;31:1433-1434

    FREE Full Text
37. Hamberg LM, Boccalini P, Stranjalis G, et al. Continuous assessment of relative cerebral blood volume in transient ischemia, using steady state susceptibility-contrast MRI. Magn Reson Med 1996;35:168-173

    PubMedWeb of Science
38. ↵
    Inoue Y, Momose T, Machida K, Honda N, Nishikawa J, Sasaki Y. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases. Radiat Med 1994;12:225-229

    PubMed
39. ↵
    Mellies JK, Baumer T, Muller JA, et al. SPECT study of a German CADASIL family: a phenotype with migraine and progressive dementia only. Neurology 1998;50:1715-1721

    Abstract/FREE Full Text
40. ↵
    Bull U, Reiche W, Kaiser HJ, et al. Cerebral blood flow to cerebral blood volume relationship as a correlate to cerebral perfusion reserve. In, Schmiedek P, Einhdupl K, Kirsch CM (eds): Stimulated Cerebral Blood Flow. Berlin: Springer; 1992:111–120
41. ↵
    Murdoch G. Staining for apoptosis: now neuropathologists can “see” leukoaraiosis. AJNR Am J Neuroradiol 2000;21:42-43

    FREE Full Text
42. Brown WR, Moody DM, Thore CR, Challa VR. Apoptosis in leukoaraiosis. AJNR Am J Neuroradiol 2000;21:79-82

    Abstract/FREE Full Text
43. ↵
    De Reuck J, Decoo D, Marchau M, Santens P, Lemahieu I, Strijckmans K. Positron emission tomography in vascular dementia. J Neurol Sci 1998;21:55-61
44. Mendez MF, Ottowitz W, Brown CV, Cummings JL, Perryman KM, Mandelkem MA. Dementia with leukoaraiosis: clinical differentiation by temporoparietal hypometabolism on (18)FDG-PET imaging. Dement Geriatr Cogn Disord 1999;10:518-525

    CrossRefPubMedWeb of Science
45. ↵
    Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1990;11:273-281

    Abstract/FREE Full Text